Cardiac stem cells for treatment of ischemic cardiomyopathy

Cardiac stem cells (CSCs), derived from the right atrial appendage were administered by intracoronary infusion, into patients with cardiomyopathy. This treatment resulted in improved left ventricular (LV) systolic function and in reduced infarct size.